Datar Cancer Genetics Unveils Exacta AI: A Revolutionary AI-Driven Cancer Treatment Platform

Metropolis Healthcare Partners with Roche to Launch Self-Sampling HPV DNA Test for Cervical Cancer Screening in India

Union Budget 2025: Full Exemption from Basic Customs Duty (BCD) for 36 Lifesaving Drugs

Dr. Jitendra Singh Inaugurates Centre for Advanced Genomics & Precision Medicine at AIIMS Jammu

Union Budget 2025-26: Key Healthcare Measures for Cancer Care and Access to Life-Saving Drugs

FDA Approves Roche’s PATHWAY HER2 Test for Identifying HER2-Ultralow Breast Cancer Patients Eligible for ENHERTU

Bristol Myers Squibb’s Breyanzi® Receives CHMP Recommendation for Relapsed or Refractory Follicular Lymphoma in the EU

NHS to Offer Groundbreaking Gene Therapy for Sickle Cell Disease

Quibim Secures $50M Series A to Advance AI-Powered Imaging for Precision Medicine

Apollo Hospitals Unveils Advanced Oncology Facility in Chennai

Beckman Coulter’s Alzheimer’s Blood Test Receives FDA Breakthrough Device Designation

ANGLE Announces Breakthrough Dual CTC-DNA and ctDNA Analysis with Illumina’s NGS Solution

Diatech Pharmacogenetics and Merck Expand Collaboration to Enhance RAS Biomarker Testing in MEA Region

DCG Unveils AI-Powered Video-Reporting for Personalized Chemotherapy Selection

FDA Approves Monthly Maintenance Dosing for LEQEMBI® in Alzheimer’s Treatment

Home
/
update
/
details

Progenesis Launches Genetic Testing Facility in India

NextEdge Admin

16 Nov 2023

1 min 39 sec

Progenesis, a leading genetic testing organization based in the USA, inaugurated its Genetic Laboratory in New Delhi and concurrently unveiled an AI & Bioinformatics Data Centre in Chennai. The event garnered significant attention from health experts, underscoring Progenesis’s unwavering commitment to genetic solutions, particularly in the realm of in vitro fertilization (IVF).

Progenesis is determined to raise awareness about genetic diseases in India by harnessing the power of artificial intelligence for precise and reliable results. Pioneering the field, the organization introduced the inaugural online portal for Preimplantation Genetic Testing, streamlining and simplifying the testing process. Dr. Nabil Arrach, the Founder & CEO of Progenesis, expressed his enthusiasm, stating, “We are thrilled to bring Progenesis to India, with our objective being a diverse market presence, extending our reach to tier-2 and tier-3 markets.”

Dr. Arrach also shed light on potential collaborations with local healthcare providers and clinics that Progenesis is considering, emphasizing the brand’s dedication to making advanced genetic testing accessible to a broader audience in India.